Azerbaijan invites hosted buyers to tourism event

Florian Sengstschmid, chief executive of ATB.
Short Url
Updated 25 February 2020

Azerbaijan invites hosted buyers to tourism event

Azerbaijan Tourism Board (ATB), the national promotion body designed to support the growth of Azerbaijan’s tourism industry, will host Travel Business Azerbaijan on April 29. Taking place in the capital Baku, this hosted buyers event will bring together local and international tourism professionals in hopes to forge partnerships and profitable business deals.

The event is a first-of-its-kind in the Caucasus country, welcoming over 400 industry professionals to establish direct communication while also serving as a platform to showcase the tourism potential of Azerbaijan.

“It’s a very exciting time for the tourism industry of Azerbaijan and we’re delighted to accelerate and enhance our proposition with Travel Business Azerbaijan. For the first time, representatives from key source markets will have the opportunity to connect with the local tourism and hospitality industry on this large scale, to build fruitful partnerships,” said Florian Sengstschmid, chief executive of ATB.

In addition to B2B meetings, the event will host an award ceremony and gala dinner, as well as both pre- and post-event FAM trips, offering guests a chance to explore the tourism, leisure and MICE potential in Baku and various regions. 

“As we continue to cater to incentives and provide unique and authentic experiences, we encourage industry professionals from around the world to join us at Travel Business Azerbaijan and discover the extraordinary amount we have to offer,” said Sengstschmid.

As part of its strategy to enhance the destination value proposition and double in-bound tourism by 2023, ATB launched its “Take another look” marketing campaign in late 2018. In just over a year, it celebrated setting a historical record for Azerbaijan with 3.2 million inbound travelers — a 11.4 percent increase over 2018.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.